Long-term survival with Gemcitabine alone chemotherapy for
non-metastatic advanced pancreatic cancer ; One case

Kim, Hyung Ook; Kim, Hungdai; Shin, Jun Ho

doi:2009.5.1.36

Korean Journal of Clinical Oncology > Article

Case Report

Korean Journal of Clinical Oncology 2009;5(1): 36-39.

비전이성 진행 췌장암에서 Gemcitabine 단독 항암 화학요법을 통한 장기 생존 1예

김형욱, 김흥대, 신준호

성균관대학교 의과대학 강북삼성병원 외과학교실

Long-term survival with Gemcitabine alone chemotherapy for non-metastatic advanced pancreatic cancer ; One case

Hyung Ook Kim, Hungdai Kim, Jun Ho Shin

Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea

Corresponding Author: Jun Ho Shin ,Tel: +82-2-2001-2138, Fax: +82-2-2001-2131, Email: junho0521.shin@samsung.com

Received: April 10, 2009; Accepted: May 7, 2009.

ABSTRACT

We report a 69-year-old male patient with non-metastatic advanced pancreatic cancer confirmed by abdominal computed tomography and intraoperative biopsy. He presented with long-term survival more than 30 months without disease progression or complication following palliative surgery and chemotherapy, after palliative choledochojejunostomy and postoperative gemcitabine alone chemotherapy.

Keywords: Pancreatic cancer | Obstructive jaundice | Palliation